BeyondSpring Inc. (BYSI) stock
BYSINasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.45−0.11 (-19.09%)
Close on Nov 18, 2026Market cap $18.63MP/E –Yield –
BeyondSpring shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
BeyondSpring's shares outstanding was 41M at Jun 30, 2026. For fiscal 2023 it was 39M, down 0.2% from the year before. The highest annual figure on record is 39M in fiscal 2022.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 39M | -0.2% |
| FY2022 | Dec 31, 2022 | 39M | +0.2% |
| FY2021 | Dec 31, 2021 | 39M | +30.1% |
| FY2020 | Dec 31, 2020 | 30M | +21.7% |
| FY2019 | Dec 31, 2019 | 25M | +8.7% |
| FY2018 | Dec 31, 2018 | 23M | +8.6% |
| FY2017 | Dec 31, 2017 | 21M | +29.7% |
| FY2016 | Dec 31, 2016 | 16M | +6.0% |
| FY2015 | Dec 31, 2015 | 15M | +9.1% |
| FY2014 | Dec 31, 2014 | 14M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 41M | +2.0% |
| Q1 FY2026 | Mar 31, 2026 | 41M | +2.0% |
| Q3 FY2025 | Sep 30, 2025 | 40M | +2.6% |
| Q2 FY2025 | Jun 30, 2025 | 40M | +3.3% |
| Q1 FY2025 | Mar 31, 2025 | 40M | +3.2% |
| Q3 FY2024 | Sep 30, 2024 | 40M | +3.3% |
| Q2 FY2024 | Jun 30, 2024 | 39M | +0.7% |
| Q1 FY2024 | Mar 31, 2024 | 39M | +0.1% |
| Q4 FY2021 | Dec 31, 2021 | 39M | +15.0% |
| Q3 FY2021 | Sep 30, 2021 | 39M | +28.8% |
| Q2 FY2021 | Jun 30, 2021 | 39M | +39.7% |
| Q1 FY2021 | Mar 31, 2021 | 39M | +40.6% |
| Q4 FY2020 | Dec 31, 2020 | 34M | +25.2% |
| Q3 FY2020 | Sep 30, 2020 | 30M | +19.7% |
| Q2 FY2020 | Jun 30, 2020 | 28M | +20.9% |
| Q1 FY2020 | Mar 31, 2020 | 28M | +20.4% |
| Q4 FY2019 | Dec 31, 2019 | 27M | +17.8% |
| Q3 FY2019 | Sep 30, 2019 | 25M | +10.3% |
| Q2 FY2019 | Jun 30, 2019 | 23M | +3.1% |
| Q1 FY2019 | Mar 31, 2019 | 23M | +3.7% |
| Q4 FY2018 | Dec 31, 2018 | 23M | +3.9% |
| Q3 FY2018 | Sep 30, 2018 | 23M | +0.5% |
| Q2 FY2018 | Jun 30, 2018 | 22M | +3.1% |
| Q1 FY2018 | Mar 31, 2018 | 22M | +24.5% |
| Q4 FY2017 | Dec 31, 2017 | 22M | +31.2% |
| Q3 FY2017 | Sep 30, 2017 | 23M | +43.2% |
| Q2 FY2017 | Jun 30, 2017 | 22M | +38.0% |
| Q1 FY2017 | Mar 31, 2017 | 18M | +13.2% |
| Q4 FY2016 | Dec 31, 2016 | 17M | – |
| Q3 FY2016 | Sep 30, 2016 | 16M | – |
| Q2 FY2016 | Jun 30, 2016 | 16M | – |
| Q1 FY2016 | Mar 31, 2016 | 16M | – |
See a number that looks wrong?